Kenneth L Londoner serves as the CEO of medical device company BioSig Technologies. This company was founded by Londoner in 2009. It has developed the PURE EP system. This is a system designed to improve Atrial Fibrillation and Ventricular Tachycardia. This is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system. Also, Londoner is the Managing Partner of Endicott Management Partners, LLC. This firm assists emerging growth companies in their corporate development and investing needs. Kenneth L Londoner previously was the executive vice president of NewCardio, Inc., a Silicon Valley based cardiac software company. He served at this position from April 2007 to October 2009. Moreover, from May 2012 to March 2014, Londoner worked at Alliqua BioMedical.